4591 - 4600 of 9039 Results
Title
Year
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4
-
OPENTitle: Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisitedJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 7Start Page: 2547End Page: 2556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23192Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23192Citation Count: 80
-
OPENTitle: Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulationJournal Name: Journal of Vascular SurgeryPublisher: Elsevier BVVol: 75Issue #: 1Start Page: 223End Page: 228Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jvs.2021.07.238Best OA location URL: http://www.jvascsurg.org/article/S0741521421019819/pdfCitation Count: 12
-
OPENTitle: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorderJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 1016End Page: 1020Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27385Best OA location URL: http://hdl.handle.net/11380/1205920Citation Count: 41
-
OPENTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Best OA location URL: https://doaj.org/article/63e10c65eb3f433c933e3bf217f2f015Citation Count: 150
- Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease2018RESTRICTEDTitle: Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 303Issue #:Start Page: 95End Page: 107Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.01.015Citation Count: 44
-
OPENTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3865178Citation Count: 66
- Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease2018OPENTitle: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 50Issue #:Start Page: 29End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5943177Citation Count: 141
- β2‐adrenoreceptor medications and risk of Parkinson disease2018RESTRICTEDTitle: β2‐adrenoreceptor medications and risk of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 5Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25341Citation Count: 86
- Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model2009RESTRICTEDTitle: Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson modelJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 219Issue #: 1Start Page: 298End Page: 307Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2009.05.033Citation Count: 93